Call +44 800 9755 164

Public tenders for healthcare in Bern Switzerland

Find all Healthcare tenders in the world.
Finding business opportunities has never been easier.

Results for healthcare. Make a new search!

Consulting Services for Healthcare Hazardous Waste Management Project (HHWMP) with the Ministry of Health in Egypt

Federal Department of Economic Affairs (FDEA), State Secretariat for Economic Affairs (SECO) on behalf of the Egyptian Ministry of Health | Published August 29, 2016  -  Deadline February 22, 2016
cpvs

Consulting Services for Healthcare Hazardous Waste Management Project (HHWMP) with the Ministry of Health in Egypt

Consulting Services for Healthcare Hazardous Waste Management Project (HHWMP) with the Ministry of Health in Egypt

Federal Department of Economic Affairs (FDEA), State Secretariat for Economic Affairs (SECO) on behalf of the Egyptian Ministry of Health | Published November 30, 2015  -  Deadline February 22, 2016
cpvs
90524400

The HHWMP aims at replacing the decentralized facilities by two large incinerators providing a safer alternative for the hospital waste management and covering the needs of the whole of Dakhaleya, a prominent Governorate located in the Nile Delta North-East of Cairo. Within the framework of the HHWMP, the Swiss Government, represented by the State Secretariat for Economic Affairs (SECO), intends to engage a Swiss Consultant for assisting the Egyptian Ministry of Health in: 1) procuring, installing and commissioning two turn-key incineration facilities and the waste collection system, as well as in establishing waste disposal sites in Dakhaleya Governorate (Provision of Infrastructure); 2) establishing a financially and administratively fully autonomous Collection, Incineration and Disposal Unit; developing regulations, guidelines and procedures; providing training (Institutional Strengthening); 3) supporting the financial sustainability, national strategy, dissemination of the model (Policy Dialogue).

Administrative healthcare services

Bundesamt für Gesundheit BAG | Published December 24, 2016  -  Deadline February 10, 2017
cpvs
75122000

Zielsetzung yesterday ist, dass die für die Prüfung Eidgenössische in Pharmazie gesamthaft zur ...

Zielsetzung yesterday ist, dass die für die Prüfung Eidgenössische in Pharmazie gesamthaft zur ...

The goal here is that the resources made available for the federal review are used in a manner consistent with the objectives, effective and ...

(17064) 316 Research Project "PT1-1-01 education: potentials" within the program interprofessionality healthcare

Bundesamt für Gesundheit BAG | Published January 31, 2017  -  Deadline March 13, 2017
cpvs
73000000

CPV: 73000000 - Research and development services and related consultancy services,
85100000 - Health services

(17071) 316 Research Project "PT1-1-02 Education: Competencies» under the support interprofessionality healthcare

Bundesamt für Gesundheit BAG | Published February 1, 2017  -  Deadline March 13, 2017
cpvs
73000000

CPV: 73000000 - Research and development services and related consultancy services,
85100000 - Health services

(17070) 316 Research Project "PT1-2-01 profession: potential" within the program interprofessionality healthcare

Bundesamt für Gesundheit BAG | Published February 1, 2017  -  Deadline March 13, 2017
cpvs
73000000

CPV: 73000000 - Research and development services and related consultancy services,
85100000 - Health services

(17069) 316 Research Project "PT1-2-07 profession: incentives" within the program interprofessionality healthcare

Bundesamt für Gesundheit BAG | Published February 1, 2017  -  Deadline March 13, 2017
cpvs
73000000

CPV: 73000000 - Research and development services and related consultancy services,
85100000 - Health services

(16240) 316 Coordination federal examinations Pharmacy

Bundesamt für Gesundheit BAG | Published December 22, 2016  -  Deadline February 10, 2017
cpvs
75122000

CPV: 75122000 - Administrative healthcare services

(16240) 316 Federal Coordination pharmacy review

Office fédéral de la santé publique OFSP | Published December 22, 2016  -  Deadline February 10, 2017
cpvs
75122000

CPV: 75122000 - Administrative healthcare services

SAPERIN - Provision of SAP integration services

Inselspital, Beschaffung und Logistik | Published November 10, 2014  -  Deadline December 15, 2014
cpvs
72000000

The hospital and healthcare market is exposed to dynamic medical and regulatory developments and continued cost pressures. Against this background, the Government of the Canton of Berne has decided in November 2009, the merger of the Inselspital University Hospital as the hospital network Bern AG to a common healthcare companies. This merger is in the form of a program called "Strengthening Medizinalstandort Bern - SMSB" implemented. One component of this program is the effort to integrate the ERP systems (ERP integration) of the two companies. It is the established already used in the Inselspital SAP system as a central ERP and the ERP of Spital Netz Bern AG - Microsoft Dynamics (Navision) - will be migrated to the SAP platform of the Inselspital.

Procurement of an Adverse Event Reporting System (AERS) (software)

Information Technology Procurement Management | Published December 8, 2015  -  Deadline February 8, 2016
cpvs
48000000

Swissmedic, the Swiss Agency for Therapeutic Products, is Switzerland's central regulatory and control authority for therapeutic products. Swissmedic's statutory mandate is set out in the Federal Act of 15 December 2000 on Medicinal Products and Medical Devices (Therapeutic Products Act, TPA; SR 812.21). As a federal public institute based in Berne, Swissmedic is independently organised and managed, and has its own budget. The core tasks of Swissmedic comprise: - Authorisation of medicinal products, - Issuing licences for manufacturing and wholesale trading, and conducting inspections, - Market surveillance of medicinal products and medical devices, - Penal law, - Clinical trials of therapeutic products and laboratory testing of the quality of medicinal products, - Drawing up legislation and standards, - Providing information to the public, - National and international cooperation Further details can be found at www.swissmedic.ch. Once medicinal products are on the market, they are subject to regulatory control. As part of its legal mandate, Swissmedic collects and evaluates reports of adverse drug reactions (ADRs) from primary reporters, in other words healthcare professionals (such as doctors, pharmacists and chemists), pharmaceutical companies and patients. These ADRs are currently collected and processed in the national VigiFlow database. This database is currently hosted and operated on Swissmedic's behalf by the Uppsala Monitoring Centre (UMC) in Sweden. The data is incorporated into the global VigiBase database, which is operated by the UMC, and is used to provide reports and consultation documents to the World Health Organization (WHO) and its member states, based on the analysis of individual case safety reports (ICSRs). Additional information on the UMC can be found here: http://www.who-umc.org VigiFlow no longer meets Swissmedic's requirements in terms of a modern pharmacovigilance tool that also offers better process support and evaluation functions for business case processing. As a result of a recent strategy review, UMC will probably only continue to support the operation of VigiFlow (enhanced version for Swissmedic) until the end of 2017. VigiFlow itself is to be replaced by a new tool that is geared to the needs of low income countries. Swissmedic therefore intends to replace VigiFlow with an up-to-date Adverse Event Reporting System (AERS) that is tailed to actual requirements by the end of 2017 at the latest. To this end, Swissmedic is seeking a supplier that can provide, in the requisite quality, a suitable standard software system plus the additional developments and services that are needed to implement this software in the Swissmedic IT architecture. The existing database from the current system will have to be imported into the new system as part of the implementation project. To cover the planned life cycle of the software, a 10-year master agreement with an option to extend for a further five years will be concluded with the successful bidder. Individual work assignments to be performed during the term of the master agreement will be subject to separate individual contracts. Once the software has been successfully implemented, the bidder must be available to maintain and support the software throughout the duration of the master agreement. Furthermore, the bidder must if necessary provide additional integration services if this is required as a result of changes in Swissmedic's IT architecture or if desired for other reasons. Swissmedic's IT environment is operated by the Swiss Federal Office of Information Technology, Systems and Telecommunication (FOITT). The FOITT provides it with computer centre, data communications and office automation services, a workstation infrastructure and associated services (PCs, notebooks and multi-function printers) as well as central security, gateway, identity and access management solutions. The software procured as result of this invitation to tender will likewise be operated at the FOITT. For specialist applications, Swissmedic also procures system operating services from the FOITT up to, and including, operation of the database management system. Swissmedic organises applications support, software product maintenance and the further development of solutions with third parties. Full details can be found in the System Specification for the invitation to tender.

Software package and information systems

Swissmedic, Informatik Beschaffungsmanagement | Published December 11, 2015  -  Deadline February 8, 2016
cpvs
48000000, 48100000, 72000000, 72200000, 72210000, 72230000, 72250000, 72260000, 72261000, 72262000, 72263000, 72265000, 72267000, 72267100, 72268000

Swissmedic, the Swiss Agency for Therapeutic Products, is Switzerland's central regulatory and control authority for therapeutic products. Swissmedic's statutory mandate is set out in the Federal Act of 15.12.2000 on Medicinal Products and Medical Devices (Therapeutic Products Act, TPA; SR 812.21). As a federal public institute based in Berne, Swissmedic is independently organised and managed, and has its own budget. The core tasks of Swissmedic comprise: — Authorisation of medicinal products, — Issuing licences for manufacturing and wholesale trading and conducting inspections, — Market surveillance of medicinal products and medical devices, — Penal law, — Clinical trials of therapeutic products and laboratory testing of the quality of medicinal products, — Drawing up legislation and standards, — Providing information to the public, — National and international cooperation. Further details can be found at: www.swissmedic.ch Once medicinal products are on the market, they are subject to regulatory control. As part of its legal mandate, Swissmedic collects and evaluates reports of adverse drug reactions (ADRs) from primary reporters, in other words healthcare professionals (such as doctors, pharmacists and chemists), pharmaceutical companies and patients. These ADRs are currently collected and processed in the national VigiFlow database. This database is currently hosted and operated on Swissmedic's behalf by the Uppsala Monitoring Centre (UMC) in Sweden. The data is incorporated into the global VigiBase database, which is operated by the UMC, and is used to provide reports and consultation documents to the World Health Organization (WHO) and its member states, based on the analysis of individual case safety reports (ICSRs). Additional information on the UMC can be found here: http://www.who-umc.org VigiFlow no longer meets Swissmedic's requirements in terms of a modern pharmacovigilance tool that also offers better process support and evaluation functions for business case processing. As a result of a recent strategy review, UMC will probably only continue to support the operation of VigiFlow (enhanced version for Swissmedic) until the end of 2017. VigiFlow itself is to be replaced by a new tool that is geared to the needs of low income countries. Swissmedic therefore intends to replace VigiFlow with an up-to-date Adverse Event Reporting System (AERS) that is tailed to actual requirements by the end of 2017 at the latest. To this end, Swissmedic is seeking a supplier that can provide, in the requisite quality, a suitable standard software system plus the additional developments and services that are needed to implement this software in the Swissmedic IT architecture. The existing database from the current system will have to be imported into the new system as part of the implementation project. To cover the planned life cycle of the software, a 10 year master agreement with an option to extend for a further 5 years will be concluded with the successful bidder. Individual work assignments to be performed during the term of the master agreement will be subject to separate individual contracts. Once the software has been successfully implemented, the bidder must be available to maintain and support the software throughout the duration of the master agreement. Furthermore, the bidder must, if necessary provide additional integration services, if this is required as a result of changes in Swissmedic's IT architecture or if desired for other reasons. Swissmedic's IT environment is operated by the Swiss Federal Office of Information Technology, Systems and Telecommunication (FOITT). The FOITT provides it with computer centre, data communications and office automation services, a workstation infrastructure and associated services (PCs, notebooks and multifunction printers) as well as central security, gateway, identity and access management solutions. The software procured as result of this invitation to tender will likewise be operated at the FOITT. For specialist applications, Swissmedic also procures system operating services from the FOITT up to, and including, operation of the database management system. Swissmedic organises applications support, software product maintenance and the further development of solutions with third parties. Full details can be found in the System Specification for the invitation to tender.
  • 1